Nano-microdelivery systems for oromucosal delivery of an active ingredient

Ioannis S. Chronakis; Lars Jørgensen; Maria Ahlm Mattebjerg

Nano-microdelivery systems for oromucosal delivery of an active ingredient

Ioannis S. Chronakis (Inventor)
, Lars Jørgensen (Inventor)
, Maria Ahlm Mattebjerg (Inventor)

National Food Institute

Research output: Patent

Abstract

A composition for oromucosal delivery of at least one active ingredient, more particularly a lipid nano-microdelivery system comprising a nicotine component and/or a flavour component, wherein the nicotine component may be delivered to the oral cavity via absorption through the mucosal membranes thereof and/or wherein the flavour component may be delivered to the oral mucosa by controlled release.

Original language	English
IPC	A61K31/465
Patent number	WO2014135630
Filing date	12/09/2014
Country/Territory	International Bureau of the World Intellectual Property Organization (WIPO)
Priority date	07/03/2013
Priority number	EP20130158191
Publication status	Published - 2014

OpenUrl availability

Check availability in DTU Findit

Cite this

@misc{46dfb46401d048298f2f45c8eeddd805,

title = "Nano-microdelivery systems for oromucosal delivery of an active ingredient",

abstract = "A composition for oromucosal delivery of at least one active ingredient, more particularly a lipid nano-microdelivery system comprising a nicotine component and/or a flavour component, wherein the nicotine component may be delivered to the oral cavity via absorption through the mucosal membranes thereof and/or wherein the flavour component may be delivered to the oral mucosa by controlled release.",

author = "Chronakis, \{Ioannis S.\} and Lars J{\o}rgensen and Mattebjerg, \{Maria Ahlm\}",

year = "2014",

language = "English",

type = "Patent",

note = "WO2014135630; A61K31/465",

}

TY - PAT

T1 - Nano-microdelivery systems for oromucosal delivery of an active ingredient

AU - Chronakis, Ioannis S.

AU - Jørgensen, Lars

AU - Mattebjerg, Maria Ahlm

PY - 2014

Y1 - 2014

N2 - A composition for oromucosal delivery of at least one active ingredient, more particularly a lipid nano-microdelivery system comprising a nicotine component and/or a flavour component, wherein the nicotine component may be delivered to the oral cavity via absorption through the mucosal membranes thereof and/or wherein the flavour component may be delivered to the oral mucosa by controlled release.

AB - A composition for oromucosal delivery of at least one active ingredient, more particularly a lipid nano-microdelivery system comprising a nicotine component and/or a flavour component, wherein the nicotine component may be delivered to the oral cavity via absorption through the mucosal membranes thereof and/or wherein the flavour component may be delivered to the oral mucosa by controlled release.

M3 - Patent

M1 - WO2014135630

Y2 - 2014/09/12

ER -

Nano-microdelivery systems for oromucosal delivery of an active ingredient

Abstract

OpenUrl availability

Fingerprint

Cite this